MIR4649: A Drug Target / Disease Biomarker (G100616346)

MIR4649: A Drug Target / Disease Biomarker

MIR4649, also known as interleukin-4649, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes several cytokines that play important roles in immune and inflammatory responses. MIR4649 has been shown to have several unique properties that make it potentially interesting as a drug target or biomarker.

One of the most significant properties of MIR4649 is its ability to interact with the protein PD-L1. PD-L1 is a protein that is expressed in many tissues, including immune cells, and plays a key role in suppressing immune responses. MIR4649 has been shown to be able to interact with PD-L1 and to inhibit its activity. This interaction between MIR4649 and PD-L1 has the potential to make MIR4649 a useful drug target for treating autoimmune diseases.

Another property of MIR4649 that makes it interesting as a drug target is its ability to regulate the activity of immune cells. MIR4649 is a cytokine that is involved in the regulation of immune cell function, including the activation and proliferation of T-cells. It has been shown to play a key role in the regulation of CD4+ T-cells, which are a crucial part of the immune system. MIR4649 has been shown to be able to regulate the activity of CD4+ T-cells and to play a role in the development of immune-related diseases.

In addition to its ability to interact with PD-L1 and regulate immune cell function, MIR4649 has also been shown to have several other unique properties that make it potentially interesting as a drug target. For example, it is a protein that is expressed in many tissues throughout the body, which makes it a potential biomarker for tracking disease. It is also a small molecule that can be easily synthesized and purified, which makes it a potential candidate for use in clinical trials.

MIR4649 has also been shown to have potential as a drug target in several different disease contexts. For example, it has been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. It has also been shown to be involved in the regulation of cancer cell growth and has been shown to have potential as a therapeutic against cancer.

In conclusion, MIR4649 is a protein that has several unique properties that make it potentially interesting as a drug target or biomarker. Its ability to interact with PD-L1 and regulate immune cell function, as well as its potential as a biomarker and its involvement in the development of autoimmune diseases and cancer make it a promising candidate for further research. Further studies are needed to fully understand the unique properties of MIR4649 and its potential as a drug target or biomarker.

Protein Name: MicroRNA 4649

The "MIR4649 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4649 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754